Publication | Closed Access
Roflumilast Altana Pharma.
47
Citations
0
References
2002
Year
AsthmaAltana PharmaMedicineActive IngredientByk GuldenHerbal MedicinePharmacotherapySpecific Pde4 InhibitorRoflumilast Altana PharmaPharmacologyDrug Discovery
Roflumilast is a specific PDE4 inhibitor being developed by Altana Pharma (formerly known as Byk Gulden) for the potential treatment of asthma and chronic obstructive pulmonary disease [312928].